Key result
Impaired LVEF and sleep-disordered breathing are linked to higher myocardial DYRK1B expression in CABG patients.
Why the study?
Recent evidence linked increased DYRK1B expression to impaired cardiac function in mice, but clinical data on myocardial DYRK1B expression in patients with cardiovascular disease and comorbidities remained scarce.
Is myocardial DYRK1B expression associated with impaired cardiac function and sleep-disordered breathing in patients undergoing coronary artery bypass surgery?
Observational (n=159)
Is myocardial DYRK1B expression associated with impaired cardiac function and sleep-disordered breathing in patients undergoing coronary artery bypass surgery?
Myocardial DYRK1B expression is increased in patients with impaired cardiac function and sleep-disordered breathing, suggesting it as a potential molecular target in HFrEF.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for DYRK1B in HFrEF with SDB; leaves open causality and therapeutic targeting pending prospective studies.
Heart failure and cardiovascular disease represent a significant burden on healthcare systems worldwide. Recent evidence associates an increased expression of the dual-specificity tyrosine phosphorylation-regulated kinase 1B (DYRK1B) with an impaired cardiac function in mice. However, there remains a paucity of data on myocardial DYRK1B expression in patients with cardiovascular disease in the context of other comorbidities. In our study, we examined DYRK1B mRNA expression in human right atrial appendage biopsies from 159 patients undergoing elective coronary artery bypass surgery. Each patient was tested for sleep-disordered breathing the night prior to surgery. In this large representative study cohort with cardiovascular high-risk patients, we found that an impaired cardiac function as well as sleep-disordered breathing (SDB), including various oxidative stress parameters, were associated with an increased myocardial DYRK1B expression. A multivariate regression analysis revealed left ventricular ejection fraction and the presence of SDB as significant predictors of the myocardial DYRK1B expression independent of other clinical covariates. Based on these findings, DYRK1B represents a promising molecular target in patients with heart failure and reduced ejection fraction as well in patients with sleep-disordered breathing.
No takes yet. Share an insight, caveat, or question.
Bayram et al. (2025) conducted an observational in Cardiovascular disease (n=159). Impaired left ventricular ejection fraction and sleep-disordered breathing were significant independent predictors of increased myocardial DYRK1B expression in patients undergoing CABG surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: